Our Exploding New Pick is Vivakor, Inc. VIVK http://www.vivakor.com/

VIVK is a trans-disciplinary biomedical/biotechnology company involved
in Discovering, Developing and Commercializing Solutions that
positively impact life. www.vivakor.com

VIVK plans to adapt a $300 Million potential technology upgrade to
produce and enhance MRI images which might improve MRI resolution
along with providing additional data such a blood flow velocity in
images tissues.

Market potential of about $15 Million just within 12 month
commercialization of the electro-optical devices released by VIVK.

VIVK have a fully integrated specialist team working on clinical trial
on Digital Photo screener, Opti-Ear and Anemia Monitor, having a
completion time of late 2009, positive results may drastically reduce
overall time and cost from previously used technology.

Experienced BOD Matthew Nicosia, Dr.Tannin Fuju and John Grayga have
strategically grown the revenue of VIVK from $20 Million to $120
Million. They approved a dividend to every share holders. Each share
holder will receive one HealthAmerica share for every share of Vivakor
Inc.

VIVK is currently in collaboration with University of IOWA, developing
a digital photo refractor that is intended to modernize child vision
screening. Approval has been granted from Western Institutional Review
Borad(20080731) to conduct human validation study.

VIVK has developed a series of nutraceutical formulations, including
VivaBlend, and plan to develop additional nutraceuticals, botanicals
and supplements. VIVK recently received 25000 units purchase order for
one of their products.

Critical advancement in the biological sample preservation are also
been evolved in VIVK. They have developed specialized Cryovials that
accommodate an improved method of cryopreservation of cells, blood and
other bio-materials.

VIVK have recently launched its sales products to Exploding Indian
Biotech market. Biopharma remains India’s biggest sector, accounting
for nearly 70% of the total revenues, expected to be worth US $5.7
Billion by 2012-2013. The future of the bio-supplier industry in India
looks very bright and so does of VIVK.

Check out Complete Presentation only at www.stockexploder.com

Please do your own due diligence on VIVK
All The Best

Exploder

www.stockexploder.com

 *Never invest in a stock mentioned by stockexploder.com unless you
can afford to lose your entire investment. For full disclaimer
http://www.stockexploder.com/disclaimer.html
Reply

Reply to all

Forward

sto

SINOBIOPHRMA INC "soared" 93% with two trading Days after my alert !
Congratulations!!!

Today SINOBIOPHRMA INC traded as high of  0.39 on over 5,000,000
shares traded

I gave this to you at 0.20 for Monday's trade....

Ok, so what’s next you ask? I have something even bigger...

Why it's in your best interest to buy  and Full Presentation on Entest
BioMedical Inc

Bio-tech companies are a great investment right now, according to many
financial experts. Support from the Obama administration will ensure
this trend continues.

Between the current administration rallying behind Bio-tech and
Stimulus plan. This is a great combo to ensure if you pick the right
Bio-tech stock you can make massive gains quickly.

"WALL STREET IS ALWAYS LOOKING” For the Next Big Thing.......

Whether it's a cure for cancer or a fountain of youth , the script
can be all-too-familiar Financially, 2009 has been a hard year.

Almost every industry sector has suffered....

But financial experts wouldn't be experts if they couldn't find a
sector that will do better than the others, and that will offer
substantial returns

to investors.

Biotech is what they recommend

Forbes interviewed two top-notch analysts in this area, Eric Schmidt
and Ross Muken. They both agree that there is money to be made by
investing in biotech.

Bottom line is this... You have a choice,

You can take action and buy Entest BioMedical Inc now!
or wait to buy it at potentially $3.50 per share

This is set to soar!!

Exploder

SINOBIOPHRMA INC "soared" 93% with two trading Days after my alert !
Congratulations!!!

Today SINOBIOPHRMA INC traded as high of  0.39 on over 5,000,000
shares traded

I gave this to you at 0.20 for Monday's trade....

Ok, so what’s next you ask? I have something even bigger...

Why it's in your best interest to buy  and Full Presentation on Entest
BioMedical Inc

Bio-tech companies are a great investment right now, according to many
financial experts. Support from the Obama administration will ensure
this trend continues.

Between the current administration rallying behind Bio-tech and
Stimulus plan. This is a great combo to ensure if you pick the right
Bio-tech stock you can make massive gains quickly.

"WALL STREET IS ALWAYS LOOKING” For the Next Big Thing.......

Whether it's a cure for cancer or a fountain of youth , the script
can be all-too-familiar Financially, 2009 has been a hard year.

Almost every industry sector has suffered....

But financial experts wouldn't be experts if they couldn't find a
sector that will do better than the others, and that will offer
substantial returns

to investors.

Biotech is what they recommend

Forbes interviewed two top-notch analysts in this area, Eric Schmidt
and Ross Muken. They both agree that there is money to be made by
investing in biotech.

Bottom line is this... You have a choice,

You can take action and buy Entest BioMedical Inc now!
or wait to buy it at potentially $3.50 per share

This is set to soar!!

Exploder

SINOBIOPHRMA INC "soared" 93% with two trading Days after my alert !
Congratulations!!!

Today SINOBIOPHRMA INC traded as high of  0.39 on over 5,000,000
shares traded

I gave this to you at 0.20 for Monday's trade....

Ok, so what’s next you ask? I have something even bigger...

Why it's in your best interest to buy  and Full Presentation on Entest
BioMedical Inc

Bio-tech companies are a great investment right now, according to many
financial experts. Support from the Obama administration will ensure
this trend continues.

Between the current administration rallying behind Bio-tech and
Stimulus plan. This is a great combo to ensure if you pick the right
Bio-tech stock you can make massive gains quickly.

"WALL STREET IS ALWAYS LOOKING” For the Next Big Thing.......

Whether it's a cure for cancer or a fountain of youth , the script
can be all-too-familiar Financially, 2009 has been a hard year.

Almost every industry sector has suffered....

But financial experts wouldn't be experts if they couldn't find a
sector that will do better than the others, and that will offer
substantial returns

to investors.

Biotech is what they recommend

Forbes interviewed two top-notch analysts in this area, Eric Schmidt
and Ross Muken. They both agree that there is money to be made by
investing in biotech.

Bottom line is this... You have a choice,

You can take action and buy Entest BioMedical Inc now!
or wait to buy it at potentially $3.50 per share

This is set to soar!!

Exploder

On Oct 4, 10:25 pm, 67mustang427SOHC <1582...@gmail.com> wrote:

On Oct 4, 9:15 pm, Wei Min Li <confidenc...@gmail.com> wrote:

On Sep 28, 6:19 am, Leone Lillig <leonelillig4...@gmail.com> wrote:

Costco Wholesale is the 5th largest retailer in the U.S. and 8th
largest in the world boasting over $87 billion in sales. They are well
diversified with over 100 warehouses in Canada, Mexico, Japan, South
Korea, Taiwan, England, Australia, and continuing to expand
internationally. Domestically they dominate in numerous markets such
as the northwest & Hawaii where other retailers are steam-rolled.
Private label product lines have been expanded providing for greater
profitability & supply chain innovations have also helped lean this
corporate giant to operate more efficiently. One factor that many miss
is that the majority of Costco locations have gasoline stations that
do huge volumes monthly versus conventional. Costco matches nearby
competitors & the constant replenishment need requires them to have
their net landed cost on gasoline hold close to daily market value. As
gasoline rises & Costco buys at the higher price before the station
down the street does, they must match & run at very low margins.
However, when oil drops (as it has lately) then Costco is the first to
buy the cheaper gasoline & can easily match & make decent margin (net
millions) while the station down the street is still trying to sell
off the remainder purchased at the higher rate.
Costco management understands that retail is in the details and has
competent leadership & an intelligently built business model to ride
through any turbulent storm and continue to triumph as ther majority
of their top sales items are staple goods that people must have
regardless of the economy & smart shoppers flock to where the value is
at by the shopping cart full. I don't know about yours, but my
confidence for this retailer was strengthened when I saw my
neighborhood Costco before the Fourth of July jam-packed in the
parking lot.
Cheers!

On Jun 17, 10:26 am, Liam <lia...@gmail.com> wrote:

On Jun 17, 9:24 am, Liam <lia...@gmail.com> wrote: